Log In
BCIQ
Print this Print this
 

CT-707

  Manage Alerts
Collapse Summary General Information
Company Beijing Sailin Tai Pharmaceutical Technology Co. Ltd.
DescriptionMulti kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today